Xiaole Shirley Liu

27PUBLICATIONS
211CO-AUTHORS
Molecular targetsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 31, 2025
Author Correction: Genetic fusions favor tumorigenesis through degron loss in oncogenes.

Jing Liu, Collin Tokheim, Jonathan D Lee

|Dec 31, 2024
Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma.

Julia Paczkowska, Ming Tang, Kyle T Wright

|Sep 01, 2024
Robust identification of perturbed cell types in single-cell RNA-seq data.

Phillip B Nicol, Danielle Paulson, Gege Qian

|Feb 22, 2023
Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell-Secreted Cytokines.

Yoshinaga Ito, Deng Pan, Wubing Zhang

|Feb 06, 2023
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha.

Avinash Sahu, Xiaoman Wang, Phillip Munson

|Oct 20, 2022
A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition.

Yadira M Soto-Feliciano, Francisco J Sánchez-Rivera, Florian Perner

Pageof 5